Suchergebnisse - "Shen, Hongtao"

PubPharm (56)

1

Transmembrane protein TMEM97 and epigenetic reader BAHCC1 constitute an axis that supports pro-inflammatory cytokine expression

enthalten in: Cellular signalling | 2024

von Li, J. | Shen, H. | Guo, L.

2

Small nucleolar RNA host gene 1 silence inhibits the lipopolysaccharide-induced microglial apoptosis and inflammation

enthalten in: Cellular and molecular biology (Noisy-le-Grand, France) | 2024

von Shen, H. | Gu, J. | Liu, X. | +1

3

Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment

enthalten in: European journal of medicinal chemistry | 2024

von Min, W. | Wang, Y. | Shen, H. | +9

4

Comparison between percutaneous short-segment fixation and percutaneous vertebroplasty in treating Kummell's disease : A minimum 2-year follow-up retrospective study

enthalten in: Journal of back and musculoskeletal rehabilitation | 2024

von Shen, H. | Tang, W. | Yin, X. | +7

5

X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles

enthalten in: Bioorganic chemistry | 2023

von Bai, C. | Lv, Y. | Xiong, S. | +13

6

Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer

enthalten in: Journal of medicinal chemistry | 2023

von Yuan, K. | Xia, F. | Li, Q. | +8

7

METTL3-mediated maturation of miR-192-5p targets ATG7 to prevent Schwann cell autophagy in peripheral nerve injury

enthalten in: Journal of neuropathology and experimental neurology | 2023

von Liu, X. | Lv, J. | Tang, W. | +3

8

[1, 2, 4] triazole [4, 3-b] pyridazine compound as well as preparation method and application thereof

enthalten in: Europäisches Patentamt | 2023

von YANG PENG | XIAO YIBEI | MIN WENJIAN | +4

9

Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1

enthalten in: Bioorganic chemistry | 2023

von Zhou, L. | Ye, X. | Wang, K. | +6

10

Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC

enthalten in: Journal of medicinal chemistry | 2023

von Dong, H. | Ye, X. | Zhu, Y. | +10

1
2
3
4
5
6
Nächster »
[6]